WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes.

AIMS Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a master regulator of oxidant and xenobiotic metabolism, but it is unknown how it is regulated to provide basal expression of this defense system. Here, we studied the putative connection between NRF2 and the canonical WNT pathway, which modulates hepatocyte metabolism. RESULTS WNT-3A increased the levels of NRF2 and its transcriptional signature in mouse hepatocytes and HEK293T cells. The use of short interfering RNAs in hepatocytes and mouse embryonic fibroblasts which are deficient in the redox sensor Kelch-like ECH-associated protein 1 (KEAP1) indicated that WNT-3A activates NRF2 in a β-Catenin- and KEAP1-independent manner. WNT-3A stabilized NRF2 by preventing its GSK-3-dependent phosphorylation and subsequent SCF/β-TrCP-dependent ubiquitination and proteasomal degradation. Axin1 and NRF2 were physically associated in a protein complex that was regulated by WNT-3A, involving the central region of Axin1 and the Neh4/Neh5 domains of NRF2. Axin1 knockdown increased NRF2 protein levels, while Axin1 stabilization with Tankyrase inhibitors blocked WNT/NRF2 signaling. The relevance of this novel pathway was assessed in mice with a conditional deletion of Axin1 in the liver, which showed upregulation of the NRF2 signature in hepatocytes and disruption of liver zonation of antioxidant metabolism. INNOVATION NRF2 takes part in a protein complex with Axin1 that is regulated by the canonical WNT pathway. This new WNT-NRF2 axis controls the antioxidant metabolism of hepatocytes. CONCLUSION These results uncover the participation of NRF2 in a WNT-regulated signalosome that participates in basal maintenance of hepatic antioxidant metabolism.

[1]  L. Staszewski,et al.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain , 1994, Cell.

[2]  L. Staszewski,et al.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. , 1994, Cell.

[3]  K. Jungermann,et al.  Zonation of parenchymal and nonparenchymal metabolism in liver. , 1996, Annual review of nutrition.

[4]  Z. Ronai,et al.  The SCFHOS/β-TRCP-ROC1 E3 Ubiquitin Ligase Utilizes Two Distinct Domains within CUL1 for Substrate Targeting and Ubiquitin Ligation , 2000, Molecular and Cellular Biology.

[5]  Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver. , 2001, The Biochemical journal.

[6]  K. Itoh,et al.  Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression* , 2003, Journal of Biological Chemistry.

[7]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[8]  J. Harper,et al.  The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase , 2004, Molecular and Cellular Biology.

[9]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[10]  D. Rickman,et al.  Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. , 2006, Developmental cell.

[11]  Akira Kobayashi,et al.  Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism , 2006, Biological chemistry.

[12]  K. Itoh,et al.  Dimerization of Substrate Adaptors Can Facilitate Cullin-mediated Ubiquitylation of Proteins by a “Tethering” Mechanism , 2006, Journal of Biological Chemistry.

[13]  A. Kong,et al.  Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. , 2006, Cancer letters.

[14]  M. Benito,et al.  Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes. , 2007, Endocrinology.

[15]  Brian N Chorley,et al.  Identification of polymorphic antioxidant response elements in the human genome. , 2007, Human molecular genetics.

[16]  P. Bugnon,et al.  Impaired liver regeneration in Nrf2 knockout mice: role of ROS‐mediated insulin/IGF‐1 resistance , 2008, The EMBO journal.

[17]  S. Monga,et al.  Wnt/β-catenin signaling in hepatic organogenesis , 2008 .

[18]  P. Rada,et al.  Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal celldeath , 2008, Molecular and Cellular Neuroscience.

[19]  S. Monga,et al.  Wnt/beta-catenin signaling in hepatic organogenesis. , 2008, Organogenesis.

[20]  Lawrence Lum,et al.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer , 2008, Nature chemical biology.

[21]  O. Sansom,et al.  Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism. , 2009, Gastroenterology.

[22]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[23]  Masayuki Yamamoto,et al.  Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver , 2010, Journal of proteomics.

[24]  Donna D. Zhang,et al.  Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. , 2010, Antioxidants & redox signaling.

[25]  M. Kwak,et al.  Regulation of Notch1 Signaling by Nrf2: Implications for Tissue Regeneration , 2010, Science Signaling.

[26]  R. Gebhardt,et al.  Organ patterning in the adult stage: The role of Wnt/β‐catenin signaling in liver zonation and beyond , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[27]  S. Colnot,et al.  Molecular determinants of liver zonation. , 2010, Progress in molecular biology and translational science.

[28]  K. Itoh,et al.  Discovery of the negative regulator of Nrf2, Keap1: a historical overview. , 2010, Antioxidants & redox signaling.

[29]  Curtis D. Klaassen,et al.  Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. , 2010, Toxicology and applied pharmacology.

[30]  Takafumi Suzuki,et al.  Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1 , 2010, Molecular and Cellular Biology.

[31]  J. Hayes,et al.  The cap'n'collar transcription factor Nrf2 mediates both intrinsic resistance to environmental stressors and an adaptive response elicited by chemopreventive agents that determines susceptibility to electrophilic xenobiotics. , 2011, Chemico-biological interactions.

[32]  P. Rada,et al.  SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.

[33]  R. Boelens,et al.  Critical scaffolding regions of the tumor suppressor Axin1 are natively unfolded. , 2011, Journal of molecular biology.

[34]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[35]  Masayuki Yamamoto,et al.  Analysis of the role of Nrf2 in the expression of liver proteins in mice using two-dimensional gel-based proteomics , 2012, Pharmacological reports : PR.

[36]  J. M. Davison,et al.  Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein through Competitive Binding to KEAP1 Protein* , 2012, The Journal of Biological Chemistry.

[37]  Hans Clevers,et al.  Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex , 2012, Cell.

[38]  G. Feng,et al.  Conditional disruption of Axin1 leads to development of liver tumors in mice. , 2012, Gastroenterology.

[39]  C. Klaassen,et al.  Effect of Graded Nrf2 Activation on Phase-I and -II Drug Metabolizing Enzymes and Transporters in Mouse Liver , 2012, PloS one.

[40]  P. Rada,et al.  Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis , 2012, Molecular and Cellular Biology.

[41]  C. Yabe-Nishimura,et al.  A crucial role for Nox 1 in redox‐dependent regulation of Wnt‐β‐catenin signaling , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  H. Aburatani,et al.  Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.

[43]  Jing Hu,et al.  Regulation of Wnt/β-catenin signaling by posttranslational modifications , 2014, Cell & Bioscience.

[44]  A. Suzuki,et al.  Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers , 2013, Molecular and Cellular Biology.

[45]  S. Ki,et al.  Role of the Nrf2-ARE Pathway in Liver Diseases , 2013, Oxidative medicine and cellular longevity.

[46]  C. Klaassen,et al.  Genetic Activation of Nrf2 Protects against Fasting-Induced Oxidative Stress in Livers of Mice , 2013, PloS one.

[47]  A. Cuadrado,et al.  Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. , 2012, Oncogene.

[48]  P. Rada,et al.  Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity , 2013, Cell Death and Disease.

[49]  P. Rada,et al.  Nuclear Import and Export Signals Control the Subcellular Localization of Nurr1 Protein in Response to Oxidative Stress* , 2013, The Journal of Biological Chemistry.

[50]  W. Weis,et al.  The β-catenin destruction complex. , 2013, Cold Spring Harbor perspectives in biology.

[51]  S. Krauss,et al.  Tankyrases as drug targets , 2013, The FEBS journal.

[52]  Miran Kim,et al.  Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. , 2013, Journal of hepatology.

[53]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[54]  S. Werner,et al.  Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell‐cycle control and apoptosis , 2014, Hepatology.

[55]  P. Rada,et al.  The PTEN/NRF2 axis promotes human carcinogenesis. , 2014, Antioxidants & redox signaling.

[56]  M. Unno,et al.  NF‐E2‐related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice , 2014, Hepatology.

[57]  S. M. Nambiar,et al.  Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver , 2014, Cell cycle.

[58]  S. Monga.  Role and regulation of β-catenin signaling during physiological liver growth. , 2014, Gene expression.

[59]  Masayuki Yamamoto,et al.  Loss of Nrf2 in mice evokes a congenital intrahepatic shunt that alters hepatic oxygen and protein expression gradients and toxicity. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.